 | • レポートコード：QYR2104Z3088 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、156ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、インドメタシンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、坐剤、注射剤、パッチ、ゼラチンパール、クリーム、その他）、用途別市場規模（非ステロイド性抗炎症薬、関節痛、筋肉痛局所投与、西洋医学発がん性鎮痛薬、月経困難症、打者症候群、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・インドメタシンの市場動向 ・企業の競争状況、市場シェア ・インドメタシンの種類別市場規模（錠剤、カプセル、坐剤、注射剤、パッチ、ゼラチンパール、クリーム、その他） ・インドメタシンの用途別市場規模（非ステロイド性抗炎症薬、関節痛、筋肉痛局所投与、西洋医学発がん性鎮痛薬、月経困難症、打者症候群、その他） ・インドメタシンの北米市場規模2016-2027（アメリカ、カナダ） ・インドメタシンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・インドメタシンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・インドメタシンの中南米市場規模2016-2027（メキシコ、ブラジル） ・インドメタシンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Iroko Pharma、Zyla Life Sciences、Kowa、Merck、H. Lumdbeck、Recordati、Druggability Technologies、AlphaRx、Cypress Bioscience、NAL Pharma、Dr. Reddy’s、Provalis、NIPRO、Shanghai Modern Pharmaceutical、Beijing Shuangji Pharmaceutical、Sinopharm Group Industry、Jiangsu Yuanheng Pharmaceutical、Hubei Dongxin Pharmaceutical、Ma Yinglong Pharmaceutical Group、Shanghai New Yellow River Pharmaceutical Co. , Ltd.、JBH Pharmaceutical Group、Linfen Baozhu Pharmaceutical、Shanxi Yunpeng Pharmaceutical、Shanxi Taiyuan Pharmaceutical、Guangdong Sancai Shiqi District Pharmaceutical、Guangdong South China Pharmaceutical Group、Jiangsu Yabang Aipusen Pharmaceutical、Chongqing Kerui Pharmaceutical Group、Beijing Honglin Pharmaceutical、Suzhou No. 3 Pharmaceutical Factory、Bedford Pharma、Northwind Pharmaceuticals、PD-Rx Pharmaceuticals） ・結論 |
Indometacin, or indomethacin, is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic properties. NSAIDs consist of agents that are structurally unrelated; the NSAID chemical classification of indometacin is an indole-acetic acid derivative with the chemical name 1- (p-chlorobenzoyl)25-methoxy-2-methylindole-3-acetic acid.The pharmacological effect of indometacin is not fully understood, however, it is thought to be mediated through potent and nonselective inhibition of the enzyme cyclooxygenase (COX), which is the main enzyme responsible for catalyzes the rate-limiting step in prostaglandin and thromboxane biosynthesis via the arachidonic acid (AA) pathway.
Market Analysis and Insights: Global Indometacin (Indomethacin) Market
The global Indometacin (Indomethacin) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Indometacin (Indomethacin) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Indometacin (Indomethacin) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Indometacin (Indomethacin) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Indometacin (Indomethacin) market.
Global Indometacin (Indomethacin) Scope and Market Size
Indometacin (Indomethacin) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Indometacin (Indomethacin) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablet
Capsule
Suppository
Injection
Patch
Gelatin Pearl
Cream
Other
Segment by Application
Nonsteroidal Anti-Inflammatory Drugs
Topical Administration For Joint And Muscle Pain
Western Medicine Carcinogenic Pain Medicine
Dysmenorrheal
Batter Syndrome
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Iroko Pharma
Zyla Life Sciences
Kowa
Merck
H. Lumdbeck
Recordati
Druggability Technologies
AlphaRx
Cypress Bioscience
NAL Pharma
Dr. Reddy’s
Provalis
NIPRO
Shanghai Modern Pharmaceutical
Beijing Shuangji Pharmaceutical
Sinopharm Group Industry
Jiangsu Yuanheng Pharmaceutical
Hubei Dongxin Pharmaceutical
Ma Yinglong Pharmaceutical Group
Shanghai New Yellow River Pharmaceutical Co. , Ltd.
JBH Pharmaceutical Group
Linfen Baozhu Pharmaceutical
Shanxi Yunpeng Pharmaceutical
Shanxi Taiyuan Pharmaceutical
Guangdong Sancai Shiqi District Pharmaceutical
Guangdong South China Pharmaceutical Group
Jiangsu Yabang Aipusen Pharmaceutical
Chongqing Kerui Pharmaceutical Group
Beijing Honglin Pharmaceutical
Suzhou No. 3 Pharmaceutical Factory
Bedford Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Indometacin (Indomethacin) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Suppository
1.2.5 Injection
1.2.6 Patch
1.2.7 Gelatin Pearl
1.2.8 Cream
1.2.9 Other
1.3 Market by Application
1.3.1 Global Indometacin (Indomethacin) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Nonsteroidal Anti-Inflammatory Drugs
1.3.3 Topical Administration For Joint And Muscle Pain
1.3.4 Western Medicine Carcinogenic Pain Medicine
1.3.5 Dysmenorrheal
1.3.6 Batter Syndrome
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Indometacin (Indomethacin) Market Perspective (2016-2027)
2.2 Indometacin (Indomethacin) Growth Trends by Regions
2.2.1 Indometacin (Indomethacin) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Indometacin (Indomethacin) Historic Market Share by Regions (2016-2021)
2.2.3 Indometacin (Indomethacin) Forecasted Market Size by Regions (2022-2027)
2.3 Indometacin (Indomethacin) Industry Dynamic
2.3.1 Indometacin (Indomethacin) Market Trends
2.3.2 Indometacin (Indomethacin) Market Drivers
2.3.3 Indometacin (Indomethacin) Market Challenges
2.3.4 Indometacin (Indomethacin) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Indometacin (Indomethacin) Players by Revenue
3.1.1 Global Top Indometacin (Indomethacin) Players by Revenue (2016-2021)
3.1.2 Global Indometacin (Indomethacin) Revenue Market Share by Players (2016-2021)
3.2 Global Indometacin (Indomethacin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Indometacin (Indomethacin) Revenue
3.4 Global Indometacin (Indomethacin) Market Concentration Ratio
3.4.1 Global Indometacin (Indomethacin) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Indometacin (Indomethacin) Revenue in 2020
3.5 Indometacin (Indomethacin) Key Players Head office and Area Served
3.6 Key Players Indometacin (Indomethacin) Product Solution and Service
3.7 Date of Enter into Indometacin (Indomethacin) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Indometacin (Indomethacin) Breakdown Data by Type
4.1 Global Indometacin (Indomethacin) Historic Market Size by Type (2016-2021)
4.2 Global Indometacin (Indomethacin) Forecasted Market Size by Type (2022-2027)
5 Indometacin (Indomethacin) Breakdown Data by Application
5.1 Global Indometacin (Indomethacin) Historic Market Size by Application (2016-2021)
5.2 Global Indometacin (Indomethacin) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Indometacin (Indomethacin) Market Size (2016-2027)
6.2 North America Indometacin (Indomethacin) Market Size by Type
6.2.1 North America Indometacin (Indomethacin) Market Size by Type (2016-2021)
6.2.2 North America Indometacin (Indomethacin) Market Size by Type (2022-2027)
6.2.3 North America Indometacin (Indomethacin) Market Size by Type (2016-2027)
6.3 North America Indometacin (Indomethacin) Market Size by Application
6.3.1 North America Indometacin (Indomethacin) Market Size by Application (2016-2021)
6.3.2 North America Indometacin (Indomethacin) Market Size by Application (2022-2027)
6.3.3 North America Indometacin (Indomethacin) Market Size by Application (2016-2027)
6.4 North America Indometacin (Indomethacin) Market Size by Country
6.4.1 North America Indometacin (Indomethacin) Market Size by Country (2016-2021)
6.4.2 North America Indometacin (Indomethacin) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Indometacin (Indomethacin) Market Size (2016-2027)
7.2 Europe Indometacin (Indomethacin) Market Size by Type
7.2.1 Europe Indometacin (Indomethacin) Market Size by Type (2016-2021)
7.2.2 Europe Indometacin (Indomethacin) Market Size by Type (2022-2027)
7.2.3 Europe Indometacin (Indomethacin) Market Size by Type (2016-2027)
7.3 Europe Indometacin (Indomethacin) Market Size by Application
7.3.1 Europe Indometacin (Indomethacin) Market Size by Application (2016-2021)
7.3.2 Europe Indometacin (Indomethacin) Market Size by Application (2022-2027)
7.3.3 Europe Indometacin (Indomethacin) Market Size by Application (2016-2027)
7.4 Europe Indometacin (Indomethacin) Market Size by Country
7.4.1 Europe Indometacin (Indomethacin) Market Size by Country (2016-2021)
7.4.2 Europe Indometacin (Indomethacin) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Indometacin (Indomethacin) Market Size (2016-2027)
8.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Type
8.2.1 Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2016-2027)
8.3 Asia-Pacific Indometacin (Indomethacin) Market Size by Application
8.3.1 Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2016-2027)
8.4 Asia-Pacific Indometacin (Indomethacin) Market Size by Region
8.4.1 Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Indometacin (Indomethacin) Market Size (2016-2027)
9.2 Latin America Indometacin (Indomethacin) Market Size by Type
9.2.1 Latin America Indometacin (Indomethacin) Market Size by Type (2016-2021)
9.2.2 Latin America Indometacin (Indomethacin) Market Size by Type (2022-2027)
9.2.3 Latin America Indometacin (Indomethacin) Market Size by Type (2016-2027)
9.3 Latin America Indometacin (Indomethacin) Market Size by Application
9.3.1 Latin America Indometacin (Indomethacin) Market Size by Application (2016-2021)
9.3.2 Latin America Indometacin (Indomethacin) Market Size by Application (2022-2027)
9.3.3 Latin America Indometacin (Indomethacin) Market Size by Application (2016-2027)
9.4 Latin America Indometacin (Indomethacin) Market Size by Country
9.4.1 Latin America Indometacin (Indomethacin) Market Size by Country (2016-2021)
9.4.2 Latin America Indometacin (Indomethacin) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Indometacin (Indomethacin) Market Size (2016-2027)
10.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Type
10.2.1 Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2016-2027)
10.3 Middle East & Africa Indometacin (Indomethacin) Market Size by Application
10.3.1 Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2016-2027)
10.4 Middle East & Africa Indometacin (Indomethacin) Market Size by Country
10.4.1 Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Iroko Pharma
11.1.1 Iroko Pharma Company Details
11.1.2 Iroko Pharma Business Overview
11.1.3 Iroko Pharma Indometacin (Indomethacin) Introduction
11.1.4 Iroko Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.1.5 Iroko Pharma Recent Development
11.2 Zyla Life Sciences
11.2.1 Zyla Life Sciences Company Details
11.2.2 Zyla Life Sciences Business Overview
11.2.3 Zyla Life Sciences Indometacin (Indomethacin) Introduction
11.2.4 Zyla Life Sciences Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.2.5 Zyla Life Sciences Recent Development
11.3 Kowa
11.3.1 Kowa Company Details
11.3.2 Kowa Business Overview
11.3.3 Kowa Indometacin (Indomethacin) Introduction
11.3.4 Kowa Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.3.5 Kowa Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Indometacin (Indomethacin) Introduction
11.4.4 Merck Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.4.5 Merck Recent Development
11.5 H. Lumdbeck
11.5.1 H. Lumdbeck Company Details
11.5.2 H. Lumdbeck Business Overview
11.5.3 H. Lumdbeck Indometacin (Indomethacin) Introduction
11.5.4 H. Lumdbeck Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.5.5 H. Lumdbeck Recent Development
11.6 Recordati
11.6.1 Recordati Company Details
11.6.2 Recordati Business Overview
11.6.3 Recordati Indometacin (Indomethacin) Introduction
11.6.4 Recordati Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.6.5 Recordati Recent Development
11.7 Druggability Technologies
11.7.1 Druggability Technologies Company Details
11.7.2 Druggability Technologies Business Overview
11.7.3 Druggability Technologies Indometacin (Indomethacin) Introduction
11.7.4 Druggability Technologies Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.7.5 Druggability Technologies Recent Development
11.8 AlphaRx
11.8.1 AlphaRx Company Details
11.8.2 AlphaRx Business Overview
11.8.3 AlphaRx Indometacin (Indomethacin) Introduction
11.8.4 AlphaRx Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.8.5 AlphaRx Recent Development
11.9 Cypress Bioscience
11.9.1 Cypress Bioscience Company Details
11.9.2 Cypress Bioscience Business Overview
11.9.3 Cypress Bioscience Indometacin (Indomethacin) Introduction
11.9.4 Cypress Bioscience Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.9.5 Cypress Bioscience Recent Development
11.10 NAL Pharma
11.10.1 NAL Pharma Company Details
11.10.2 NAL Pharma Business Overview
11.10.3 NAL Pharma Indometacin (Indomethacin) Introduction
11.10.4 NAL Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.10.5 NAL Pharma Recent Development
11.11 Dr. Reddy’s
11.11.1 Dr. Reddy’s Company Details
11.11.2 Dr. Reddy’s Business Overview
11.11.3 Dr. Reddy’s Indometacin (Indomethacin) Introduction
11.11.4 Dr. Reddy’s Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.11.5 Dr. Reddy’s Recent Development
11.12 Provalis
11.12.1 Provalis Company Details
11.12.2 Provalis Business Overview
11.12.3 Provalis Indometacin (Indomethacin) Introduction
11.12.4 Provalis Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.12.5 Provalis Recent Development
11.13 NIPRO
11.13.1 NIPRO Company Details
11.13.2 NIPRO Business Overview
11.13.3 NIPRO Indometacin (Indomethacin) Introduction
11.13.4 NIPRO Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.13.5 NIPRO Recent Development
11.14 Shanghai Modern Pharmaceutical
11.14.1 Shanghai Modern Pharmaceutical Company Details
11.14.2 Shanghai Modern Pharmaceutical Business Overview
11.14.3 Shanghai Modern Pharmaceutical Indometacin (Indomethacin) Introduction
11.14.4 Shanghai Modern Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.14.5 Shanghai Modern Pharmaceutical Recent Development
11.15 Beijing Shuangji Pharmaceutical
11.15.1 Beijing Shuangji Pharmaceutical Company Details
11.15.2 Beijing Shuangji Pharmaceutical Business Overview
11.15.3 Beijing Shuangji Pharmaceutical Indometacin (Indomethacin) Introduction
11.15.4 Beijing Shuangji Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.15.5 Beijing Shuangji Pharmaceutical Recent Development
11.16 Sinopharm Group Industry
11.16.1 Sinopharm Group Industry Company Details
11.16.2 Sinopharm Group Industry Business Overview
11.16.3 Sinopharm Group Industry Indometacin (Indomethacin) Introduction
11.16.4 Sinopharm Group Industry Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.16.5 Sinopharm Group Industry Recent Development
11.17 Jiangsu Yuanheng Pharmaceutical
11.17.1 Jiangsu Yuanheng Pharmaceutical Company Details
11.17.2 Jiangsu Yuanheng Pharmaceutical Business Overview
11.17.3 Jiangsu Yuanheng Pharmaceutical Indometacin (Indomethacin) Introduction
11.17.4 Jiangsu Yuanheng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.17.5 Jiangsu Yuanheng Pharmaceutical Recent Development
11.18 Hubei Dongxin Pharmaceutical
11.18.1 Hubei Dongxin Pharmaceutical Company Details
11.18.2 Hubei Dongxin Pharmaceutical Business Overview
11.18.3 Hubei Dongxin Pharmaceutical Indometacin (Indomethacin) Introduction
11.18.4 Hubei Dongxin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.18.5 Hubei Dongxin Pharmaceutical Recent Development
11.18 Ma Yinglong Pharmaceutical Group
11.25.1 Ma Yinglong Pharmaceutical Group Company Details
11.25.2 Ma Yinglong Pharmaceutical Group Business Overview
11.25.3 Ma Yinglong Pharmaceutical Group Indometacin (Indomethacin) Introduction
11.25.4 Ma Yinglong Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.25.5 Ma Yinglong Pharmaceutical Group Recent Development
11.20 Shanghai New Yellow River Pharmaceutical Co. , Ltd.
11.20.1 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Company Details
11.20.2 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Business Overview
11.20.3 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Indometacin (Indomethacin) Introduction
11.20.4 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.20.5 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Recent Development
11.21 JBH Pharmaceutical Group
11.21.1 JBH Pharmaceutical Group Company Details
11.21.2 JBH Pharmaceutical Group Business Overview
11.21.3 JBH Pharmaceutical Group Indometacin (Indomethacin) Introduction
11.21.4 JBH Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.21.5 JBH Pharmaceutical Group Recent Development
11.22 Linfen Baozhu Pharmaceutical
11.22.1 Linfen Baozhu Pharmaceutical Company Details
11.22.2 Linfen Baozhu Pharmaceutical Business Overview
11.22.3 Linfen Baozhu Pharmaceutical Indometacin (Indomethacin) Introduction
11.22.4 Linfen Baozhu Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.22.5 Linfen Baozhu Pharmaceutical Recent Development
11.23 Shanxi Yunpeng Pharmaceutical
11.23.1 Shanxi Yunpeng Pharmaceutical Company Details
11.23.2 Shanxi Yunpeng Pharmaceutical Business Overview
11.23.3 Shanxi Yunpeng Pharmaceutical Indometacin (Indomethacin) Introduction
11.23.4 Shanxi Yunpeng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.23.5 Shanxi Yunpeng Pharmaceutical Recent Development
11.24 Shanxi Taiyuan Pharmaceutical
11.24.1 Shanxi Taiyuan Pharmaceutical Company Details
11.24.2 Shanxi Taiyuan Pharmaceutical Business Overview
11.24.3 Shanxi Taiyuan Pharmaceutical Indometacin (Indomethacin) Introduction
11.24.4 Shanxi Taiyuan Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.24.5 Shanxi Taiyuan Pharmaceutical Recent Development
11.25 Guangdong Sancai Shiqi District Pharmaceutical
11.25.1 Guangdong Sancai Shiqi District Pharmaceutical Company Details
11.25.2 Guangdong Sancai Shiqi District Pharmaceutical Business Overview
11.25.3 Guangdong Sancai Shiqi District Pharmaceutical Indometacin (Indomethacin) Introduction
11.25.4 Guangdong Sancai Shiqi District Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.25.5 Guangdong Sancai Shiqi District Pharmaceutical Recent Development
11.26 Guangdong South China Pharmaceutical Group
11.26.1 Guangdong South China Pharmaceutical Group Company Details
11.26.2 Guangdong South China Pharmaceutical Group Business Overview
11.26.3 Guangdong South China Pharmaceutical Group Indometacin (Indomethacin) Introduction
11.26.4 Guangdong South China Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.26.5 Guangdong South China Pharmaceutical Group Recent Development
11.27 Jiangsu Yabang Aipusen Pharmaceutical
11.27.1 Jiangsu Yabang Aipusen Pharmaceutical Company Details
11.27.2 Jiangsu Yabang Aipusen Pharmaceutical Business Overview
11.27.3 Jiangsu Yabang Aipusen Pharmaceutical Indometacin (Indomethacin) Introduction
11.27.4 Jiangsu Yabang Aipusen Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.27.5 Jiangsu Yabang Aipusen Pharmaceutical Recent Development
11.28 Chongqing Kerui Pharmaceutical Group
11.28.1 Chongqing Kerui Pharmaceutical Group Company Details
11.28.2 Chongqing Kerui Pharmaceutical Group Business Overview
11.28.3 Chongqing Kerui Pharmaceutical Group Indometacin (Indomethacin) Introduction
11.28.4 Chongqing Kerui Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.28.5 Chongqing Kerui Pharmaceutical Group Recent Development
11.29 Beijing Honglin Pharmaceutical
11.29.1 Beijing Honglin Pharmaceutical Company Details
11.29.2 Beijing Honglin Pharmaceutical Business Overview
11.29.3 Beijing Honglin Pharmaceutical Indometacin (Indomethacin) Introduction
11.29.4 Beijing Honglin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.29.5 Beijing Honglin Pharmaceutical Recent Development
11.30 Suzhou No. 3 Pharmaceutical Factory
11.30.1 Suzhou No. 3 Pharmaceutical Factory Company Details
11.30.2 Suzhou No. 3 Pharmaceutical Factory Business Overview
11.30.3 Suzhou No. 3 Pharmaceutical Factory Indometacin (Indomethacin) Introduction
11.30.4 Suzhou No. 3 Pharmaceutical Factory Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.30.5 Suzhou No. 3 Pharmaceutical Factory Recent Development
11.31 Bedford Pharma
11.31.1 Bedford Pharma Company Details
11.31.2 Bedford Pharma Business Overview
11.31.3 Bedford Pharma Indometacin (Indomethacin) Introduction
11.31.4 Bedford Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.31.5 Bedford Pharma Recent Development
11.32 Northwind Pharmaceuticals
11.32.1 Northwind Pharmaceuticals Company Details
11.32.2 Northwind Pharmaceuticals Business Overview
11.32.3 Northwind Pharmaceuticals Indometacin (Indomethacin) Introduction
11.32.4 Northwind Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.32.5 Northwind Pharmaceuticals Recent Development
11.33 PD-Rx Pharmaceuticals
11.33.1 PD-Rx Pharmaceuticals Company Details
11.33.2 PD-Rx Pharmaceuticals Business Overview
11.33.3 PD-Rx Pharmaceuticals Indometacin (Indomethacin) Introduction
11.33.4 PD-Rx Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021)
11.33.5 PD-Rx Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Indometacin (Indomethacin) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablet
Table 3. Key Players of Capsule
Table 4. Key Players of Suppository
Table 5. Key Players of Injection
Table 6. Key Players of Patch
Table 7. Key Players of Gelatin Pearl
Table 8. Key Players of Cream
Table 9. Key Players of Other
Table 10. Global Indometacin (Indomethacin) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Indometacin (Indomethacin) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Indometacin (Indomethacin) Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Indometacin (Indomethacin) Market Share by Regions (2016-2021)
Table 14. Global Indometacin (Indomethacin) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Indometacin (Indomethacin) Market Share by Regions (2022-2027)
Table 16. Indometacin (Indomethacin) Market Trends
Table 17. Indometacin (Indomethacin) Market Drivers
Table 18. Indometacin (Indomethacin) Market Challenges
Table 19. Indometacin (Indomethacin) Market Restraints
Table 20. Global Indometacin (Indomethacin) Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Indometacin (Indomethacin) Market Share by Players (2016-2021)
Table 22. Global Top Indometacin (Indomethacin) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Indometacin (Indomethacin) as of 2020)
Table 23. Ranking of Global Top Indometacin (Indomethacin) Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Indometacin (Indomethacin) Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Indometacin (Indomethacin) Product Solution and Service
Table 27. Date of Enter into Indometacin (Indomethacin) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Indometacin (Indomethacin) Revenue Market Share by Type (2016-2021)
Table 31. Global Indometacin (Indomethacin) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Indometacin (Indomethacin) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Indometacin (Indomethacin) Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Indometacin (Indomethacin) Revenue Market Share by Application (2016-2021)
Table 35. Global Indometacin (Indomethacin) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Indometacin (Indomethacin) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million)
Table 67. Iroko Pharma Company Details
Table 68. Iroko Pharma Business Overview
Table 69. Iroko Pharma Indometacin (Indomethacin) Product
Table 70. Iroko Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 71. Iroko Pharma Recent Development
Table 72. Zyla Life Sciences Company Details
Table 73. Zyla Life Sciences Business Overview
Table 74. Zyla Life Sciences Indometacin (Indomethacin) Product
Table 75. Zyla Life Sciences Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 76. Zyla Life Sciences Recent Development
Table 77. Kowa Company Details
Table 78. Kowa Business Overview
Table 79. Kowa Indometacin (Indomethacin) Product
Table 80. Kowa Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 81. Kowa Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Indometacin (Indomethacin) Product
Table 85. Merck Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. H. Lumdbeck Company Details
Table 88. H. Lumdbeck Business Overview
Table 89. H. Lumdbeck Indometacin (Indomethacin) Product
Table 90. H. Lumdbeck Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 91. H. Lumdbeck Recent Development
Table 92. Recordati Company Details
Table 93. Recordati Business Overview
Table 94. Recordati Indometacin (Indomethacin) Product
Table 95. Recordati Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 96. Recordati Recent Development
Table 97. Druggability Technologies Company Details
Table 98. Druggability Technologies Business Overview
Table 99. Druggability Technologies Indometacin (Indomethacin) Product
Table 100. Druggability Technologies Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 101. Druggability Technologies Recent Development
Table 102. AlphaRx Company Details
Table 103. AlphaRx Business Overview
Table 104. AlphaRx Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 105. AlphaRx Recent Development
Table 106. Cypress Bioscience Company Details
Table 107. Cypress Bioscience Business Overview
Table 108. Cypress Bioscience Indometacin (Indomethacin) Product
Table 109. Cypress Bioscience Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 110. Cypress Bioscience Recent Development
Table 111. NAL Pharma Company Details
Table 112. NAL Pharma Business Overview
Table 113. NAL Pharma Indometacin (Indomethacin) Product
Table 114. NAL Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 115. NAL Pharma Recent Development
Table 116. Dr. Reddy’s Company Details
Table 117. Dr. Reddy’s Business Overview
Table 118. Dr. Reddy’s Indometacin (Indomethacin) Product
Table 119. Dr. Reddy’s Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 120. Dr. Reddy’s Recent Development
Table 121. Provalis Company Details
Table 122. Provalis Business Overview
Table 123. Provalis Indometacin (Indomethacin) Product
Table 124. Provalis Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 125. Provalis Recent Development
Table 126. NIPRO Company Details
Table 127. NIPRO Business Overview
Table 128. NIPRO Indometacin (Indomethacin) Product
Table 129. NIPRO Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 130. NIPRO Recent Development
Table 131. Shanghai Modern Pharmaceutical Company Details
Table 132. Shanghai Modern Pharmaceutical Business Overview
Table 133. Shanghai Modern Pharmaceutical Indometacin (Indomethacin) Product
Table 134. Shanghai Modern Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 135. Shanghai Modern Pharmaceutical Recent Development
Table 136. Beijing Shuangji Pharmaceutical Company Details
Table 137. Beijing Shuangji Pharmaceutical Business Overview
Table 138. Beijing Shuangji Pharmaceutical Indometacin (Indomethacin) Product
Table 139. Beijing Shuangji Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 140. Beijing Shuangji Pharmaceutical Recent Development
Table 141. Sinopharm Group Industry Company Details
Table 142. Sinopharm Group Industry Business Overview
Table 143. Sinopharm Group Industry Indometacin (Indomethacin) Product
Table 144. Sinopharm Group Industry Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 145. Sinopharm Group Industry Recent Development
Table 146. Jiangsu Yuanheng Pharmaceutical Company Details
Table 147. Jiangsu Yuanheng Pharmaceutical Business Overview
Table 148. Jiangsu Yuanheng Pharmaceutical Indometacin (Indomethacin) Product
Table 149. Jiangsu Yuanheng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 150. Jiangsu Yuanheng Pharmaceutical Recent Development
Table 151. Hubei Dongxin Pharmaceutical Company Details
Table 152. Hubei Dongxin Pharmaceutical Business Overview
Table 153. Hubei Dongxin Pharmaceutical Indometacin (Indomethacin) Product
Table 154. Hubei Dongxin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 155. Hubei Dongxin Pharmaceutical Recent Development
Table 156. Ma Yinglong Pharmaceutical Group Company Details
Table 157. Ma Yinglong Pharmaceutical Group Business Overview
Table 158. Ma Yinglong Pharmaceutical Group Indometacin (Indomethacin) Product
Table 159. Ma Yinglong Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 160. Ma Yinglong Pharmaceutical Group Recent Development
Table 161. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Company Details
Table 162. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Business Overview
Table 163. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Indometacin (Indomethacin) Product
Table 164. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 165. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Recent Development
Table 166. JBH Pharmaceutical Group Company Details
Table 167. JBH Pharmaceutical Group Business Overview
Table 168. JBH Pharmaceutical Group Indometacin (Indomethacin) Product
Table 169. JBH Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 170. JBH Pharmaceutical Group Recent Development
Table 171. Linfen Baozhu Pharmaceutical Company Details
Table 172. Linfen Baozhu Pharmaceutical Business Overview
Table 173. Linfen Baozhu Pharmaceutical Indometacin (Indomethacin) Product
Table 174. Linfen Baozhu Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 175. Linfen Baozhu Pharmaceutical Recent Development
Table 176. Shanxi Yunpeng Pharmaceutical Company Details
Table 177. Shanxi Yunpeng Pharmaceutical Business Overview
Table 178. Shanxi Yunpeng Pharmaceutical Indometacin (Indomethacin) Product
Table 179. Shanxi Yunpeng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 180. Shanxi Yunpeng Pharmaceutical Recent Development
Table 181. Shanxi Taiyuan Pharmaceutical Company Details
Table 182. Shanxi Taiyuan Pharmaceutical Business Overview
Table 183. Shanxi Taiyuan Pharmaceutical Indometacin (Indomethacin)Product
Table 184. Shanxi Taiyuan Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 185. Shanxi Taiyuan Pharmaceutical Recent Development
Table 186. Guangdong Sancai Shiqi District Pharmaceutical Company Details
Table 187. Guangdong Sancai Shiqi District Pharmaceutical Business Overview
Table 188. Guangdong Sancai Shiqi District Pharmaceutical Indometacin (Indomethacin) Product
Table 189. Guangdong Sancai Shiqi District Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 190. Guangdong Sancai Shiqi District Pharmaceutical Recent Development
Table 191. Guangdong South China Pharmaceutical Group Company Details
Table 192. Guangdong South China Pharmaceutical Group Business Overview
Table 193. Guangdong South China Pharmaceutical Group Indometacin (Indomethacin) Product
Table 194. Guangdong South China Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 195. Guangdong South China Pharmaceutical Group Recent Development
Table 196. Jiangsu Yabang Aipusen Pharmaceutical Company Details
Table 197. Jiangsu Yabang Aipusen Pharmaceutical Business Overview
Table 198. Jiangsu Yabang Aipusen Pharmaceutical Indometacin (Indomethacin) Product
Table 199. Jiangsu Yabang Aipusen Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 200. Jiangsu Yabang Aipusen Pharmaceutical Recent Development
Table 201. Chongqing Kerui Pharmaceutical Group Company Details
Table 202. Chongqing Kerui Pharmaceutical Group Business Overview
Table 203. Chongqing Kerui Pharmaceutical Group Indometacin (Indomethacin) Product
Table 204. Chongqing Kerui Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 205. Chongqing Kerui Pharmaceutical Group Recent Development
Table 206. Beijing Honglin Pharmaceutical Company Details
Table 207. Beijing Honglin Pharmaceutical Business Overview
Table 208. Beijing Honglin Pharmaceutical Indometacin (Indomethacin) Product
Table 209. Beijing Honglin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 210. Beijing Honglin Pharmaceutical Recent Development
Table 211. Suzhou No. 3 Pharmaceutical Factory Company Details
Table 212. Suzhou No. 3 Pharmaceutical Factory Business Overview
Table 213. Suzhou No. 3 Pharmaceutical Factory Indometacin (Indomethacin) Product
Table 214. Suzhou No. 3 Pharmaceutical Factory Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 215. Suzhou No. 3 Pharmaceutical Factory Recent Development
Table 216. Bedford Pharma Company Details
Table 217. Bedford Pharma Business Overview
Table 218. Bedford Pharma Indometacin (Indomethacin) Product
Table 219. Bedford Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 220. Bedford Pharma Recent Development
Table 221. Northwind Pharmaceuticals Company Details
Table 222. Northwind Pharmaceuticals Business Overview
Table 223. Northwind Pharmaceuticals Indometacin (Indomethacin) Product
Table 224. Northwind Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 225. Northwind Pharmaceuticals Recent Development
Table 226. PD-Rx Pharmaceuticals Company Details
Table 227. PD-Rx Pharmaceuticals Business Overview
Table 228. PD-Rx Pharmaceuticals Indometacin (Indomethacin) Product
Table 229. PD-Rx Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million)
Table 230. PD-Rx Pharmaceuticals Recent Development
Table 231. Research Programs/Design for This Report
Table 232. Key Data Information from Secondary Sources
Table 233. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Indometacin (Indomethacin) Market Share by Type: 2020 VS 2027
Figure 2. Tablet Features
Figure 3. Capsule Features
Figure 4. Suppository Features
Figure 5. Injection Features
Figure 6. Patch Features
Figure 7. Gelatin Pearl Features
Figure 8. Cream Features
Figure 9. Other Features
Figure 10. Global Indometacin (Indomethacin) Market Share by Application: 2020 VS 2027
Figure 11. Nonsteroidal Anti-Inflammatory Drugs Case Studies
Figure 12. Topical Administration For Joint And Muscle Pain Case Studies
Figure 13. Western Medicine Carcinogenic Pain Medicine Case Studies
Figure 14. Dysmenorrheal Case Studies
Figure 15. Batter Syndrome Case Studies
Figure 16. Other Case Studies
Figure 17. Indometacin (Indomethacin) Report Years Considered
Figure 18. Global Indometacin (Indomethacin) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Indometacin (Indomethacin) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Indometacin (Indomethacin) Market Share by Regions: 2020 VS 2027
Figure 21. Global Indometacin (Indomethacin) Market Share by Regions (2022-2027)
Figure 22. Global Indometacin (Indomethacin) Market Share by Players in 2020
Figure 23. Global Top Indometacin (Indomethacin) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Indometacin (Indomethacin) as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Indometacin (Indomethacin) Revenue in 2020
Figure 25. Global Indometacin (Indomethacin) Revenue Market Share by Type (2016-2021)
Figure 26. Global Indometacin (Indomethacin) Revenue Market Share by Type (2022-2027)
Figure 27. North America Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Indometacin (Indomethacin) Market Share by Type (2016-2027)
Figure 29. North America Indometacin (Indomethacin) Market Share by Application (2016-2027)
Figure 30. North America Indometacin (Indomethacin) Market Share by Country (2016-2027)
Figure 31. United States Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Indometacin (Indomethacin) Market Share by Type (2016-2027)
Figure 35. Europe Indometacin (Indomethacin) Market Share by Application (2016-2027)
Figure 36. Europe Indometacin (Indomethacin) Market Share by Country (2016-2027)
Figure 37. Germany Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Indometacin (Indomethacin) Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Indometacin (Indomethacin) Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Indometacin (Indomethacin) Market Share by Region (2016-2027)
Figure 47. China Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Indometacin (Indomethacin) Market Share by Type (2016-2027)
Figure 55. Latin America Indometacin (Indomethacin) Market Share by Application (2016-2027)
Figure 56. Latin America Indometacin (Indomethacin) Market Share by Country (2016-2027)
Figure 57. Mexico Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Indometacin (Indomethacin) Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Indometacin (Indomethacin) Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Indometacin (Indomethacin) Market Share by Country (2016-2027)
Figure 63. Turkey Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Iroko Pharma Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 67. Zyla Life Sciences Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 68. Kowa Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 70. H. Lumdbeck Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 71. Recordati Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 72. Druggability Technologies Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 73. AlphaRx Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 74. Cypress Bioscience Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 75. NAL Pharma Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 76. Dr. Reddy’s Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 77. Provalis Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 78. NIPRO Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 79. Shanghai Modern Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 80. Beijing Shuangji Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 81. Sinopharm Group Industry Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 82. Jiangsu Yuanheng Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 83. Hubei Dongxin Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 84. Ma Yinglong Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 85. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 86. JBH Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 87. Linfen Baozhu Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 88. Shanxi Yunpeng Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 89. Shanxi Taiyuan Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 90. Guangdong Sancai Shiqi District Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 91. Guangdong South China Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 92. Jiangsu Yabang Aipusen Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 93. Chongqing Kerui Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 94. Beijing Honglin Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 95. Suzhou No. 3 Pharmaceutical Factory Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 96. Bedford Pharma Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 97. Northwind Pharmaceuticals Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 98. PD-Rx Pharmaceuticals Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- 世界の局所鎮痛剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Topical Pain Relievers Market The global Topical Pain Relievers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の局所疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Topical Pain Management Therapeutics Market The global Topical Pain Management Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の鎮痛剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pain Relievers Market The global Pain Relievers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界の神経因性疼痛治療薬市場規模・現状・予測（2021年-2027年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…